C79.10
Secondary malignant neoplasm of unspecified urinary organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the urinary organs refers to cancer that has spread (metastasized) to the urinary system from a primary site elsewhere in the body. When the specific urinary organ affected cannot be identified, or when the origin of the metastatic disease is unclear, the diagnosis is classified as 'unspecified.' This condition signifies an advanced stage of cancer, requiring detailed medical evaluation and tailored treatment plans. Recognizing the nature and implications of this diagnosis can help patients better understand their health situation and the importance of ongoing medical care.
Causes & Symptoms
Clinical Causes: Metastatic spread from primary cancers such as lung, breast, colon, or melanoma Advanced stage carcinomas originating outside the urinary system Unidentified primary tumors that have metastasized to urinary organs
Key Symptoms: Unexplained hematuria (blood in urine) Lower back pain or discomfort Persistent urinary symptoms like urgency or frequency Unintended weight loss Fatigue and general weakness Swelling or masses in the abdomen or pelvic area
Diagnostic & Treatment
Diagnosis Path: Medical history review and physical examination Urinalysis to detect abnormal cells or blood Imaging tests such as CT scans, MRI, or ultrasound to locate tumors and assess their extent Biopsy procedures to obtain tissue samples for histopathological analysis Additional tests to identify the primary tumor site if not already known
Treatment Protocols: Chemotherapy to target cancer cells throughout the body Radiation therapy to control localized tumors and alleviate symptoms Surgical intervention, which may involve removal of affected tissues or organs Targeted therapy or immunotherapy when specific molecular markers are identified Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C79.10 a billable ICD-10 code?
Yes, C79.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.10?
Clinical documentation must specify the nature of Secondary malignant neoplasm of unspecified urinary organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference